Medical Properties Trust Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Medical Properties Trust stock has a consensus rating of "Hold" and an average price target of $3.55. The average 1-year stock price forecast is 112.57% higher than the current stock price, while the lowest is $2.00 (+19.76%) and the highest is $5.00 (+199.40%).

Price Target: $3.55 (+112.57%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$2.00	$3.55	$3.50	$5.00
Change	+19.76%	+112.57%	+109.58%	+199.40%

Analyst Ratings

The average analyst rating for Medical Properties Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	0	0	0	0	0	0
Buy	3	3	3	3	3	2
Hold	3	3	3	3	2	3
Sell	2	2	2	2	3	2
Strong Sell	1	1	1	0	0	0
Total	9	9	9	8	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Farrell Granath Bank of America Securities	Bank of America Securities	Sell Reiterates $4.25 → $1.75	Sell	Reiterates	$4.25 → $1.75	+4.79%	Nov 9, 2026
Nate Crossett Exane BNP Paribas	Exane BNP Paribas	Hold Downgrades $2.25	Hold	Downgrades	$2.25	+34.73%	Nov 3, 2026
Michael Diana Maxim Group	Maxim Group	Buy Reiterates $7 → $5	Buy	Reiterates	$7 → $5	+199.40%	Oct 31, 2026
Michael Carroll RBC Capital	RBC Capital	Sell Downgrades $4.5 → $2	Sell	Downgrades	$4.5 → $2	+19.76%	Oct 30, 2026
Michael Mueller J.P. Morgan	J.P. Morgan	Sell Maintains n/a	Sell	Maintains	n/a	n/a	Sep 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.00B

from 1.07B

-6.08%

from 1.07B

Revenue Next Year

1.05B

from 1.00B

4.41%

from 1.00B

EPS This Year

0.11

EPS Next Year

-0.03

from 0.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.57B	1.58B	885.77M	1.04B	1.07B	1.00B
Revenue Growth	23.90%	0.67%	-44.07%	17.38%	2.90%	-6.08%
Net Income	656.02M	902.60M	-556.48M	-2.41B	-277.05M	193.09M
EPS	-	-	-	-	-	0.11
Dividend / Share	1.12	1.16	0.88	0.46	0.33	0.36
Dividend Growth	3.70%	3.57%	-24.14%	-47.73%	-28.26%	9.09%
FFO	975.99M	934.31M	287.79M	-1.40B	183.92M	287.21M
FFO / Share	1.65	1.56	0.48	-2.33	0.31	0.48
P/FFO	9.42	5.08	8.20	-1.49	15.18	3.48
No. Analysts	-	-	-	-	-	2

EPS based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.0B
Avg	1.0B
Low	991.6M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-4.8%
Avg	-6.1%
Low	-7.3%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.11
Avg	0.11
Low	0.11

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-